Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-10-19
DOI
10.1038/s41416-020-01116-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systematic review with meta-analysis: the critical role of dermatological events in patients with hepatocellular carcinoma treated with sorafenib
- (2019) Álvaro Díaz-González et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients
- (2019) Francesco Tovoli et al. JOURNAL OF HEPATOLOGY
- Older Patients (Still) Left Out of Cancer Clinical Trials
- (2019) Jennifer Abbasi JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Outcomes based on age in the phase 3 CELESTIAL trial of cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC).
- (2018) Lorenza Rimassa et al. JOURNAL OF CLINICAL ONCOLOGY
- Sorafenib as first-line therapy in patients with advanced Child-Pugh B hepatocellular carcinoma—a meta-analysis
- (2018) Mairéad Geraldine McNamara et al. EUROPEAN JOURNAL OF CANCER
- Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma
- (2017) Dimitrios C. Ziogas et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Starting Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study
- (2017) Kim A. Reiss et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies
- (2017) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- How do oncologists make decisions about chemotherapy for their older patients with cancer? A survey of Australian oncologists
- (2017) E. B. Moth et al. SUPPORTIVE CARE IN CANCER
- Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non–Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study
- (2016) Romain Corre et al. JOURNAL OF CLINICAL ONCOLOGY
- Hepatocellular carcinoma in the elderly: Meta-analysis and systematic literature review
- (2015) Annie K Hung WORLD JOURNAL OF GASTROENTEROLOGY
- Sorafenib use in elderly patients with hepatocellular carcinoma: caution about use of platelet aggregation inhibitors
- (2014) Julien Edeline et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Efficacy and safety of sorafenib in very elderly patients aged 80 years and older with advanced hepatocellular carcinoma
- (2014) Masayasu Jo et al. HEPATOLOGY RESEARCH
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Early dermatologic adverse events predict better outcome in HCC patients treated with sorafenib
- (2014) Maria Reig et al. JOURNAL OF HEPATOLOGY
- Safety of Sorafenib Therapy in Elderly Adults with Advanced Hepatocellular Carcinoma
- (2014) Edoardo Francini et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Sorafenib Therapy for BCLC Stage B/C Hepatocellular Carcinoma; Clinical Outcome and Safety in Aged Patients: A Multicenter Study in Japan
- (2014) Hiroki Nishikawa et al. Journal of Cancer
- Targeted Therapy for Advanced Hepatocellular Cancer in the Elderly: Focus on Sorafenib
- (2013) D. Germano et al. DRUGS & AGING
- Is the efficacy of sorafenib treatment in patients with hepatocellular carcinoma affected by age?
- (2013) Giuseppe Cabibbo et al. Expert Review of Anticancer Therapy
- Impact of age on toxicity and efficacy of sorafenib-targeted therapy in cirrhotic patients with hepatocellular carcinoma
- (2013) Giovan Giuseppe Di Costanzo et al. MEDICAL ONCOLOGY
- The influence of clinical assessment (including age) and geriatric assessment on treatment decisions in older patients with cancer
- (2013) Lore Decoster et al. Journal of Geriatric Oncology
- Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis
- (2012) T. Pressiani et al. ANNALS OF ONCOLOGY
- Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy
- (2011) Massimo Iavarone et al. HEPATOLOGY
- Higher discontinuation and lower survival rates are likely in elderly Japanese patients with advanced hepatocellular carcinoma receiving sorafenib
- (2011) Manabu Morimoto et al. HEPATOLOGY RESEARCH
- Imputing missing covariate values for the Cox model
- (2009) Ian R. White et al. STATISTICS IN MEDICINE
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started